MedDay In $10.5 Million Series A Funding Backed By Sofinnova, InnoBio
This article was originally published in The Pink Sheet Daily
Executive Summary
France's MedDay attracts venture capital and government funding to treat rare metabolic disorders linked to CNS conditions like MS, schizophrenia and Alzheimer's disease.